Melanoma 2013: Standard Treatment, Novel Therapies, and Ongoing Controversies

The Midwest Melanoma Partnership (MMP) is a multi-institutional group of physicians, scientists and patient advocates dedicated to the development of improved therapies for patients with malignant melanoma. The purpose of this activity is to promote collaborative clinical studies built upon the expertise of a multidisciplinary, multi-institutional team of scientists and physicians. The morning meeting sessions (only open to partnership members), will be followed by an afternoon CME conference on brain metastases from melanoma. This event is open to anyone with an interest in melanoma prevention, treatment and research. This multidisciplinary conference will provide clinicians with information on state-of-the-art treatment and diagnostic modalities, therapeutic management and clinical support issues, that are relevant to a unique and challenging patient population.